Key Insights
High Adoption Rate of Therapeutic Antibodies in Cost-Sensitive Markets
High cost of drugs, particularly biologics, is becoming an increasingly important issue in controlling healthcare cost. Economic burden of cancer and other chronic diseases is increasing with increasing healthcare expenditure. Improvements in production technologies of therapeutic antibodies has decreased the manufacturing cost and thus, penetration of antibodies has increased in cost-sensitive markets, such as Japan, Brazil and China.

Source: Click here